Want to join the conversation?
$AMGN posted a 15% increase in GAAP earnings in 2Q16, helped by higher revenues and higher operating margins compared to 2Q15. Net income was $1.87Bil or $2.47 per diluted share compared to $1.65Bil or $2.15 per diluted share last year. Revenue grew 6% versus 2Q15 to $5.7Bil. Non-GAAP EPS increased 11% to $2.84.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?